Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Macro Group Pharmaceuticals (Macro Capital) Co Pretax Margin %?
Macro Group Pharmaceuticals (Macro Capital) CoCAI:MCRO -0.66%38 Pretax Margin % is 16.23% as of Mar. 2026, which is 51% below its 10-year median of 33.06. GuruFocus rates CAI:MCRO with a GF Score™ of 38/100. The stock has 2 warning signs investors should review. Among 1,958 Consumer Packaged Goods companies, Macro Group Pharmaceuticals (Macro Capital) Co ranks better than 85.34% on this metric.
CAI:MCRO'
s Pretax Margin % Range Over the Past 10 Years
Min: 16.41 Med: 33.06 Max: 41.27
Current: 16.41
CAI:MCRO's Pretax Margin % is ranked better than 85.34% of 1958
companies
in the Consumer Packaged Goods industry
Industry Median: 4.69
vs CAI:MCRO: 16.41
Macro Group Pharmaceuticals (Macro Capital) Co (CAI:MCRO) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Macro Group Pharmaceuticals (Macro Capital) Co Pretax Margin % Related Terms
Macro Group Pharmaceuticals (Macro Capital) Co Pretax Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Macro Group Pharmaceuticals (Macro Capital) Co Pretax Margin % Chart
Macro Group Pharmaceuticals (Macro Capital) Co Annual Data
Trend
Dec20
Dec21
Dec22
Pretax Margin %
41.27
33.06
31.16
Macro Group Pharmaceuticals (Macro Capital) Co Quarterly Data
CAI:MCRO vs PG, CL, KVUE: Pretax Margin % Comparison
For the Household & Personal Products subindustry, Macro Group Pharmaceuticals (Macro Capital) Co's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Macro Group Pharmaceuticals (Macro Capital) Co Pretax Margin % vs Consumer Packaged Goods Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Macro Group Pharmaceuticals (Macro Capital) Co (CAI:MCRO) has a Pretax Margin % of 16.23% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Macro Group Pharmaceuticals (Macro Capital) Co and its competitors. This is 51% below median its historical median of 33.06. Over the past decade, Macro Group Pharmaceuticals (Macro Capital) Co's Pretax Margin % has ranged from 16.41 to 41.27. According to the industry distribution chart, Macro Group Pharmaceuticals (Macro Capital) Co ranks #287 out of 1958 companies in the Consumer Packaged Goods industry, placing it in the top 14.7%.
Is Macro Group Pharmaceuticals (Macro Capital) Co's Pretax Margin % too high?
Macro Group Pharmaceuticals (Macro Capital) Co's current Pretax Margin % of 16.23% is 51% below median its 10-year median of 33.06. Over the past 10 years, this metric has ranged from a low of 16.41 to a high of 41.27. The Consumer Packaged Goods industry median Pretax Margin % is 4.69. Macro Group Pharmaceuticals (Macro Capital) Co's value of 16.23% is 246.1% above this industry median. Based on the distribution chart, Macro Group Pharmaceuticals (Macro Capital) Co ranks #287 out of 1958 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Macro Group Pharmaceuticals (Macro Capital) Co has a GF Score™ of 38/100, reflecting its overall financial health beyond just this single metric.
How does Macro Group Pharmaceuticals (Macro Capital) Co's Pretax Margin % compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Macro Group Pharmaceuticals (Macro Capital) Co ranks #287 out of 1958 companies for Pretax Margin %. This places Macro Group Pharmaceuticals (Macro Capital) Co in the top 15% of its industry — outperforming the majority of peers. The industry median Pretax Margin % is 4.69. Macro Group Pharmaceuticals (Macro Capital) Co's value of 16.23% is 246.1% above this benchmark. Historically, Macro Group Pharmaceuticals (Macro Capital) Co's own Pretax Margin % has ranged from 16.41 to 41.27 over the past decade. While the company's 10-year median is 33.06 vs. the industry median of 4.69, Macro Group Pharmaceuticals (Macro Capital) Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Consumer Packaged Goods company?
The median Pretax Margin % among Consumer Packaged Goods companies is 4.69, based on 1,958 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Macro Group Pharmaceuticals (Macro Capital) Co's current Pretax Margin % of 16.23% is 246.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Macro Group Pharmaceuticals (Macro Capital) Co and its competitors. For the Consumer Packaged Goods industry, the median Pretax Margin % is 4.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Macro Group Pharmaceuticals (Macro Capital) Co's current Pretax Margin % is 16.23%, which is 51% below median its own 10-year median of 33.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Macro Group Pharmaceuticals (Macro Capital) Co stock overvalued right now?
Macro Group Pharmaceuticals (Macro Capital) Co (CAI:MCRO) has a current Pretax Margin % of 16.23%. The current Pretax Margin % is 16.23%, which is 51% below median its 10-year median of 33.06 and 246.1% above the Consumer Packaged Goods industry median of 4.69. Macro Group Pharmaceuticals (Macro Capital) Co's overall GF Score™ is 38/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Macro Group Pharmaceuticals (Macro Capital) Co (CAI:MCRO), the current Pretax Margin % is 16.23% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Macro Group Pharmaceuticals (Macro Capital) Co is principally engaged in the manufacture and sale of cosmeceutical and ventured into nutraceutical products.
38GF Score
Get the complete analysis for CAI:MCRO
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CAI:MCRO has been successfully added to your 
